Kaj Blennow

6 ta ish

University of Gothenburg

1. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

   Clifford R. Jack, David A. Bennett, Kaj Blennow +22

   Sharh maqolaOAOchiq kirish20184 iqtibos

   ABIABI:AkademIndex/2026.other.037883

2. Biomarkers for Alzheimer's disease: current status and prospects for the future

   Kaj Blennow, Henrik Zetterberg

   Sharh maqolaOAOchiq kirish20183 iqtibos

   ABIABI:AkademIndex/2026.other.247102

3. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

   Kaj Blennow, Harald Hampel, Michael W. Weiner +1

   Sharh maqola20103 iqtibos

   ABIABI:AkademIndex/2026.other.292441

4. Blood biomarkers for Alzheimer’s disease in clinical practice and trials

   Oskar Hansson, Kaj Blennow, Henrik Zetterberg +1

   Sharh maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.292542

5. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

   Piotr Lewczuk, Peter Riederer, Sid E. O’Bryant +55

   Sharh maqola20173 iqtibos

   ABIABI:AkademIndex/2026.other.480895

6. <scp>CSF</scp> A<i>β</i>42/A<i>β</i>40 and A<i>β</i>42/A<i>β</i>38 ratios: better diagnostic markers of Alzheimer disease

   Shorena Janelidze, Henrik Zetterberg, Niklas Mattsson +9

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.775815